CA2240271A1 - Utilisation de certains composes d'isoquinolinesulfonyle dans le traitement de glaucomes et d'ischemies oculaires - Google Patents

Utilisation de certains composes d'isoquinolinesulfonyle dans le traitement de glaucomes et d'ischemies oculaires

Info

Publication number
CA2240271A1
CA2240271A1 CA002240271A CA2240271A CA2240271A1 CA 2240271 A1 CA2240271 A1 CA 2240271A1 CA 002240271 A CA002240271 A CA 002240271A CA 2240271 A CA2240271 A CA 2240271A CA 2240271 A1 CA2240271 A1 CA 2240271A1
Authority
CA
Canada
Prior art keywords
glaucoma
treatment
compounds
ocular ischemia
ocular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002240271A
Other languages
English (en)
Other versions
CA2240271C (fr
Inventor
Michael A. Kapin
Louis M. Desantis, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US1996/020197 external-priority patent/WO1997023222A1/fr
Publication of CA2240271A1 publication Critical patent/CA2240271A1/fr
Application granted granted Critical
Publication of CA2240271C publication Critical patent/CA2240271C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002240271A 1995-12-21 1996-12-20 Utilisation de certains composes d'isoquinolinesulfonyle dans le traitement de glaucomes et d'ischemies oculaires Expired - Fee Related CA2240271C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US935195P 1995-12-21 1995-12-21
US60/009,351 1995-12-21
PCT/US1996/020197 WO1997023222A1 (fr) 1995-12-21 1996-12-20 Utilisation de certains composes d'isoquinolinesulfonyle dans le traitement de glaucomes et d'ischemies oculaires

Publications (2)

Publication Number Publication Date
CA2240271A1 true CA2240271A1 (fr) 1997-07-03
CA2240271C CA2240271C (fr) 2005-12-13

Family

ID=35517628

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002240271A Expired - Fee Related CA2240271C (fr) 1995-12-21 1996-12-20 Utilisation de certains composes d'isoquinolinesulfonyle dans le traitement de glaucomes et d'ischemies oculaires

Country Status (1)

Country Link
CA (1) CA2240271C (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696194B2 (en) 2001-04-11 2010-04-13 Senju Pharmaceutical Co., Ltd. Visual function disorder improving agents
US7964613B2 (en) 2007-02-28 2011-06-21 Asahi Kasei Pharma Corporation Sulfonamide compound

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008105058A1 (fr) 2007-02-27 2008-09-04 Asahi Kasei Pharma Corporation Sulfamides
AU2008272396B2 (en) 2007-07-02 2011-09-08 Asahi Kasei Pharma Corporation Sulfonamide Compound and Crystal Thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696194B2 (en) 2001-04-11 2010-04-13 Senju Pharmaceutical Co., Ltd. Visual function disorder improving agents
US7964613B2 (en) 2007-02-28 2011-06-21 Asahi Kasei Pharma Corporation Sulfonamide compound

Also Published As

Publication number Publication date
CA2240271C (fr) 2005-12-13

Similar Documents

Publication Publication Date Title
MX9805033A (es) Uso de ciertos compuestos de isoquinolinosulfonilo para el tratamiento de glaucoma e isquemia ocular.
EP1225168A3 (fr) Dérivés de prostaglandines pour le traitement du glaucome et de l'hypertension oculaire
CA2102241A1 (fr) Traitement des affections oculaires avec des macrolides
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
WO1996002264A3 (fr) Compositions contenant du dioxyde de chlore a utilisation ophtalmique
AU8060394A (en) Ophthalmic formulation useful in the treatment of dry eye syndrom
CA2315829A1 (fr) Agents angiostatiques et compositions permettant de lutter contre l'hypertension intra-oculaire
WO1998020880A3 (fr) 11-halo prostaglandines destinees au traitement du glaucome ou de l'hypertension oculaire
EP0366279A3 (fr) Agents oculaires hypotenseurs
WO2000018316A3 (fr) Composition ophtalmique agreable, a liberation prolongee, et procede de therapie oculaire
WO1998039293A3 (fr) 13-thia prostaglandines destinees a etre utilisees dans la therapie du glaucome
AU687906B2 (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
CA2180846A1 (fr) Procede de traitement des maladies de l'oeil
AU2001278708A1 (en) Adenosine derivatives and use thereof
CA2240271A1 (fr) Utilisation de certains composes d'isoquinolinesulfonyle dans le traitement de glaucomes et d'ischemies oculaires
WO1995016435A3 (fr) Solution d'irrigation intraoculaire amelioree contenat un agent anti-inflammatoire non-steroidien
CA2353527A1 (fr) Utilisation de stimulateurs des facteurs neurotrophiques pour le traitement des affections neurodegeneratives ophtalmiques
EP1121932A4 (fr) Medicaments pour maladies oculaires
CA2140010A1 (fr) Regulation de la coagulation du sang a l'aide d'un produit contenant du tcf-ii comme ingredient actif
AU2155995A (en) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
DE69829062D1 (de) Verwendung von flunarizin zur topischen behandlung ocularem hochdruck
CA2042936A1 (fr) Traitement de l'hypertension oculaire au moyen d'une combinaison synergique pour utilisation ophtalmique
EP0784983A3 (fr) Utilisation d'hemoglobine extracellulaire
EP0345028A3 (fr) Utilisation d'un inhibiteur de la phosphodiestérase pour le traitement du glaucome
WO2000064425A3 (fr) Compositions ophtalmiques pour traiter les troubles visuels caracterises par une sensibilite au contraste reduite

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed